Non-proliferative chronic myelomonocytic leukemia (CMML)
Showing 1 - 25 of >10,000
MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)
Recruiting
- Myelodysplastic Syndromes
- Chronic Myelomonocytic Leukemia
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Jul 30, 2023
Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)
Not yet recruiting
- Chronic Myelomonocytic Leukemia
- CD4CAR
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Oct 2, 2023
Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- Leukemia
-
Tampa, Florida
- +4 more
Nov 11, 2022
Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)
Active, not recruiting
- Myelofibrosis
- Chronic Myelomonocytic Leukemia
-
Duarte, California
- +9 more
Jan 24, 2023
Recurrent Chronic Myelomonocytic Leukemia, Refractory Chronic Myelomonocytic Leukemia Trial in Rochester (Biospecimen
Recruiting
- Recurrent Chronic Myelomonocytic Leukemia
- Refractory Chronic Myelomonocytic Leukemia
- Biospecimen Collection
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Leukemia, Leukemia, Myeloid, Monocytic Leukemia Trial in Palo Alto (Enasidenib mesylat dose escalation)
Recruiting
- Leukemia
- +2 more
- Enasidenib mesylat dose escalation
-
Palo Alto, CaliforniaStanford Cancer Institute
May 12, 2022
MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)
Recruiting
- Myelodysplastic Syndromes
- +2 more
- unrelated umbilical cord blood
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Oct 16, 2022
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul
Active, not recruiting
- Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
- (no location specified)
Nov 29, 2022
MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,
Not yet recruiting
- Myelodysplastic Syndromes
- +2 more
- Venetoclax
- +4 more
-
Aachen, NRW, Germany
- +2 more
Mar 29, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Carboplatin
- +3 more
-
Los Angeles, California
- +5 more
Jan 27, 2023
Recurrent Chronic Myelomonocytic Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Chronic Myelomonocytic Leukemia Trial
Recruiting
- Recurrent Chronic Myelomonocytic Leukemia
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jul 21, 2022
Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))
Completed
- Chronic Myelomonocytic Leukemia
- +4 more
- Imatinib Mesylate (Gleevec)
-
Houston, TexasUT MD Anderson Cancer Center
Dec 7, 2021
Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in Houston (Decitabine and Cedazuridine, Venetoclax)
Recruiting
- Chronic Myelomonocytic Leukemia
- Myelodysplastic Syndrome
- Decitabine and Cedazuridine
- Venetoclax
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Miltenyi CliniMACS Prodigy ® system
- (no location specified)
Mar 23, 2023
Azacitidine in International Prognostic Scoring System
Recruiting
- Myelodysplastic Syndromes
- +2 more
-
Hefei, Anhui, China
- +16 more
Sep 6, 2022
Hematologic Malignancy Trial in Guangzhou (BC3402 Injection)
Not yet recruiting
- Hematologic Malignancy
- BC3402 Injection
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Jinan University
Jan 10, 2023
MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Huddinge, Uppsala (NEX-18a injection,
Terminated
- Myelodysplastic Syndromes (MDS)
- +2 more
- NEX-18a injection
- Azacitidine Injection
-
Huddinge, Sweden
- +1 more
Apr 4, 2022
GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)
Recruiting
- GVHD
- +15 more
- FLUDARABINE
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 30, 2021